维普期刊资源整合服务平台（V6.5）

146篇 您的检索式：作者名="Aapro MS"

选中清除导出查看参考文献查看引证文献引用追踪共8页首页上一页第1页下一页末页 /8 跳转

	题名	作者	年代	出处	被引量
1	Anticipatory nausea and vomiting显示文摘	Roscoe JA Morrow GR Aapro MS	2011	Supportive Care in Cancer2011，19，：	1
2	Palonosetron as an anti-emetic and anti-nausea agent in oncology显示文摘	Aapro MS	2007	Ther Clin Risk Manag2007，3，6：	1
3	Palonosetron (PALO) is effective in preventing acute and delayed chemotherapy - induced nausea and vomiting (CINV) in patients receiving highly emetogenic chemotherapy ( HEC ) 显示文摘	Aapro MS Bertoli L Lordick F	2003	Supportive Care Cancer2003，11，6：	1
4	Gemeitabine-a safety review 显示文摘	Aapro MS Martin C Hatty S	1998	Anticancer Drugs1998，9，3：	1
5	EORTC guidelines for the use of granulocyte - colony stimulating factor to reduce the inci- dence of Chemotherapy ~ induced febrile rteiaii'openia in adult pa- tients with iymphomas and solid tumours显示文摘	Aapro MS Cameron DA Pettengell R	2006	Eur J Cancer2006，42，15：	1
6	ESMO minimum clinical recommendations for prophylaxis of chemotherapy-induced nausea and vomiting (NV)显示文摘	Herrstedt J Aapro MS Roila F	2005	Ann On col2005，16，1：	1
7	The incidence of anticipatory nausea and vomiting after reapeat cycle chemotherapy: the effect of granisetron 显示文摘	Aapro MS Kirchner V Terrey JP	1994	Br J Cancer1994，69，5：	1
8	EORTC guidelines for the use of erythmpoietic proteins in anenlic patients with cancer:2006 update显示文摘	Bokemeyer C Aapro MS Courdi A	2007	Eur J Cancer2007，43，：	1
9	Comparative activity of an- tiemetic drugs显示文摘	Jordan K Schmoll HJ Aapro MS	2007	Crit Rev On- col Hematol2007，61，2：	1
10	Dexamethasone as an antiemeticin patients treated with cisplatin显示文摘	Aapro MS Alberts DS	1981	New England Journal ofMedieine1981，305，9：	1
11	A phase III, double-blind, randomized trial of palonosetron compared with on- dansetron in preventing chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy显示文摘	Aapro MS Grunberg SM Manikhas GM	2006	Ann On- col2006，17，9：	1
12	2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours显示文摘	Aapro MS Bohlius J Cameron DA	2011	Eur J Cancer2011，47，1：	1
13	Never too old? Age should not be a barrier to enrollment in cancer clinical trials显示文摘	Aapro MS Kohne CH Cohen HJ	2005	Oneologist2005，10，3：	1
14	Palonosetron as an anti-emctic and antinausea agent in oncology显示文摘	Aapro MS	2007	Ther Clin Risk Manag2007，3，6：	1
15	Practical guidance for the management of aromatase inhibitor-associated bone loss显示文摘	Hadji P Body JJ Aapro MS	2008	Ann Oncol2008，19，8：	1
16	Compamtive activity ofantiemetic drugs显示文摘	Jordan K Schmoll HJ Aapro MS	2007	Crit Rev oncol Hematol2007，61，2：	1
17	A randomized double-blind trial to compare the clinical efficacy of granisetron with metoclopramide, both combined with dexamethasone in the prophylaxis of chemotherapy-induced delayed emesis显示文摘	Aapro MS Thuerlimann B Sessa C	2003	Ann Oncol2003，14，2：	1
18	Gemcitabine-a safety re- view显示文摘	Aapro MS Martin C Hatty S	1998	Anticancer Drugs1998，9，3：	1
19	Palonosetron as an anti-emetic and anti-nausea agent in oncology 显示文摘	Aapro MS	2007	Ther Clin Risk Manag2007，3，6：	1
20	Management of aromatase inhibitor-associated bone loss in postmenopausal women with breast cancer :practical guidance for prevention and treatment 显示文摘	Hadji P Aapro MS Body JJ	2011	Ann Oncol2011，22，12：	1

返回顶部每页显示：

共8页首页上一页第1页下一页末页 /8 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示